Malignancy phenotype in common variable immunodeficiency

Journal of Investigational Allergology and Clinical Immunology

Volumn 22, Issue 2, 2012, Pages 133-134

  Abolhassani, H ^a   Aghamohammadi, A ^a,b   Imanzadeh, A ^a   Mohammadinejad, P ^a   Sadeghi, B ^a   Rezaei, N ^a,b  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Common variable immunodeficiency; Gastric adenocarcinoma; Malignancy phenotype; Non Hodgkin lymphoma

Indexed keywords

CD4 ANTIGEN;

ADOLESCENT; ADULT; ARTICLE; CANCER MORTALITY; CANCER RISK; CANCER SURVIVAL; CD4 LYMPHOCYTE COUNT; CHILD; CHROMOSOMAL INSTABILITY; COMMON VARIABLE IMMUNODEFICIENCY; CONTROLLED STUDY; FEMALE; HODGKIN DISEASE; HUMAN; IMMUNE DEFICIENCY; INFECTION SENSITIVITY; IRAN; MAJOR CLINICAL STUDY; MALE; NONHODGKIN LYMPHOMA; ONSET AGE; PHENOTYPE; PREVALENCE; SCHOOL CHILD; STOMACH ADENOCARCINOMA;

ADOLESCENT; CHILD; COMMON VARIABLE IMMUNODEFICIENCY; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; PHENOTYPE;

EID: 84860235073     PISSN: 10189068     EISSN: 16980808     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Aghamohammadi A, Farhoudi A, Moin M, Rezaei N, Kouhi A, Pourpak Z, Yaseri N, Movahedi M, Gharagozlou M, Zandieh F, et al. Clinical and immunological features of 65 Iranian patients with common variable immunodeficiency. Clin Diagn Lab Immunol. 2005;12:825-32.
2. Cunningham-Rundles C, and Bodian C. Common variable immunodeficiency: clinical and immunological features of 248 patients. Clin Immunol. 1999;92:34-48.
3. Hermaszewski R A, and Webster A D. Primary hypogammaglobulinaemia: a survey of clinical manifestations and complications. Q J Med. 1993;86:31-42.
4. Knight A K, and Cunningham-Rundles C. Inflammatory and autoimmune complications of common variable immune deficiency. Autoimmun Rev. 2006;5:156-9.
5. Mellemkjaer L, Hammarstrom L, Andersen V, Yuen J, Heilmann C, Barington T, Bjorkander J, and Olsen J H. Cancer risk among patients with IgA deficiency or common variable immunodeficiency and their relatives: a combined Danish and Swedish study. Clin Exp Immunol. 2002;130:495-500.
6. Montazeri A. Quality of life data as prognostic indicators of survival in cancer patients: an overview of the literature from 1982 to 2008. Health Qual Life Outcomes. 2009;7:102.
7. Cunningham-Rundles C, Siegal F P, Cunningham-Rundles S, and Lieberman P. Incidence of cancer in 98 patients with common varied immunodeficiency. J Clin Immunol. 1987;7:294-9.
8. Chua I, Quinti I, and Grimbacher B. Lymphoma in common variable immunodeficiency: interplay between immune dysregulation, infection and genetics. Curr Opin Hematol. 2008;15:368-74.
9. Kinlen L J, Webster A D, Bird A G, Haile R, Peto J, Soothill J F, and Thompson R A. Prospective study of cancer in patients with hypogammaglobulinaemia. Lancet. 1985;1:263-6.
10. Filipovich A H, Heinitz K J, Robison L L, and Frizzera G. The Immunodeficiency Cancer Registry. A research resource. Am J Pediatr Hematol Oncol. 1987;9:183-4.